SURGICEL ABSORBABLE HEMOSTAT
Report
- Report Number
- 2210968-2012-07943
- Event Type
- Injury
- Date Received
- December 6, 2012
- Date of Event
- November 13, 2012
- Report Date
- November 19, 2012
- Manufacturer
- ETHICON, INC.
- Product Code
- LMG
- PMA / PMN Number
- N12159
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4). CONCLUSION: THE PRODUCT UPON WHICH THIS MEDWATCH IS BASED IS ANTICIPATED. ONCE THE PRODUCT IS RECEIVED, ANY FURTHER INFORMATION DERIVED FROM THE EVALUATION WILL BE SUBMITTED IN A SUPPLEMENTAL 3500A FORM. IN ADDITION, A REVIEW OF THE BATCH MANUFACTURING RECORDS WAS CONDUCTED AND THE BATCH MET ALL FINISHED GOODS RELEASE CRITERIA.
(B)(4). CONCLUSION: NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY. ONE UNOPENED REPRESENTATIVE SAMPLE WAS VISUAL EXAMINATION. THE FOIL POUCH REVEALED THAT THERE WAS A TEAR ON THE UPPER RIGHT CORNER OF THE POUCH AND ANOTHER TEAR IN THE BOTTOM LEFT CORNER OF THE POUCH. THE TEARS SEEM TO BE RELATED TO AN ATTEMPT TO OPEN THE FOIL POUCH OR PRODUCT HANDLING SUBSEQUENT TO THE MANUFACTURING OF THE PRODUCT. THE EVALUATION BEING PERFORMED IS OF A REPRESENTATIVE SAMPLE. THE CONDITION OF THE FOIL POUCH USED ON THE OPERATION IS NOT KNOWN.
IT WAS REPORTED THAT A PATIENT UNDERWENT A RESECTION OF A SMALL HEPATOCELLULAR CARCINOMA ON (B)(6) 2012 AND AN ABSORBABLE HEMOSTATIC AGENT WAS USED. AFTER THE FIRST POST OPERATIVE DAY THE PATIENT DEVELOPED A FEVER AND YELLOW DRAINAGE. THE SURGEON DRAINED THE FLUID THROUGH DRAINAGE TUBE. THE PATIENT IS NOW IN GOOD CONDITION. ADDITIONAL INFORMATION HAS BEEN REQUESTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | SURGICEL ABSORBABLE HEMOSTAT | HEMOSTATIC AGENT, ABSORBABLE | LMG | ETHICON, INC. | NA | EDB175-1 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 40 YR | Required Intervention |